Arthur Joseph Mccullough

Arthur Joseph Mccullough's AcademicInfluence.com Rankings

Engineering

#3342

World Rank

#4404

Historical Rank

Biomedical Engineering

#153

World Rank

#156

Historical Rank

engineering Degrees

Arthur Joseph Mccullough

Philosophy

#4822

World Rank

#7474

Historical Rank

Logic

#2199

World Rank

#3137

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Arthur Joseph Mccullough's Degrees

Doctorate Medicine Harvard University

Why Is Arthur Joseph Mccullough Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Arthur Joseph Mccullough's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005) (8022)
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. (1999) (3267)
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. (2001) (2434)
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010) (2333)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2015) (1763)
Association of nonalcoholic fatty liver disease with insulin resistance. (1999) (1500)
Insulin resistance: A metabolic pathway to chronic liver disease (2005) (837)
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease (2006) (678)
Clinical features and natural history of nonalcoholic steatosis syndromes. (2001) (678)
Long-term follow-up of patients with nonalcoholic fatty liver. (2009) (663)
Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study (2009) (658)
Endpoints and clinical trial design for nonalcoholic steatohepatitis (2011) (635)
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. (2004) (535)
Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. (2009) (477)
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future (2007) (450)
Pathophysiology of nonalcoholic steatohepatitis. (2006) (427)
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease (2010) (420)
Plasma metabolomic profile in nonalcoholic fatty liver disease. (2011) (392)
Nonalcoholic fatty liver disease in patients with type 2 diabetes. (2004) (365)
Update on nonalcoholic fatty liver disease. (2002) (364)
Alcoholic liver disease (2010) (341)
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C (2002) (331)
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo‐controlled trial (2011) (330)
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. (1998) (316)
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. (2016) (304)
Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases–U.S. Food and Drug Administration Joint Workshop (2015) (284)
Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology (1998) (269)
Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. (1990) (262)
Hepatic iron and nonalcoholic fatty liver disease (1999) (240)
Role of ceramides in nonalcoholic fatty liver disease (2012) (239)
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). (2012) (236)
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) (2013) (229)
Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study (2009) (199)
Late evening snack: Exploiting a period of anabolic opportunity in cirrhosis (2012) (187)
Pathogenesis of non-alcoholic steatohepatitis: human data. (2007) (177)
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. (1992) (176)
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. (2011) (172)
Fatty liver disease: NASH and related disorders (2004) (172)
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. (2017) (167)
Metabolic and molecular responses to leucine‐enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis (2015) (167)
Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis (2015) (165)
Disordered energy and protein metabolism in liver disease. (1991) (157)
Diagnosis of Wilson's disease presenting as fulminant hepatic failure. (1983) (156)
The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View. (2018) (155)
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. (2004) (154)
Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent (2013) (154)
Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease (2012) (151)
Diabetes mellitus, obesity, and hepatic steatosis. (2002) (151)
Reply: Comments on AASLD practice guidelines for alcoholic liver disease (2010) (150)
Posttransplant metabolic syndrome: An epidemic waiting to happen (2009) (147)
Gender-dependent alterations in serum leptin in alcoholic cirrhosis. (1998) (147)
Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation (2014) (146)
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients (2013) (145)
Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism (2012) (143)
Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis (2015) (143)
Measurements of total body and extracellular water in cirrhotic patients with and without ascites (1991) (140)
Epidemiology of the metabolic syndrome in the USA (2011) (135)
Afternoon Colonoscopies Have Higher Failure Rates than Morning Colonoscopies (2006) (134)
A randomized blinded clinical trial of a rapid colonic lavage solution (Golytely) compared with standard preparation for colonoscopy and barium enema. (1983) (127)
Natural History of Nonalcoholic Fatty Liver Disease (2016) (124)
The Epidemiology and Risk Factors of NASH (2007) (123)
The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation (2008) (118)
Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C (2004) (117)
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. (2019) (114)
Leucine metabolism in stable cirrhosis (1986) (108)
Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. (2004) (107)
Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non‐alcoholic fatty liver disease (2014) (107)
Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. (1997) (106)
Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment (2006) (104)
Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis (2011) (103)
Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. (2013) (98)
Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. (2012) (96)
Sarcopenia associated with portosystemic shunting is reversed by follistatin. (2011) (93)
Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. (2010) (93)
Steatohepatitis in obese individuals. (2002) (90)
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow‐up study (2012) (90)
A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. (1995) (90)
Gender differences in leucine, but not lysine, kinetics. (2001) (88)
Diagnosis and management of alcoholic liver disease (2011) (88)
Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. (2008) (86)
Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study (2017) (82)
Renin‐angiotensin system and fibrosis in non‐alcoholic fatty liver disease (2015) (81)
Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity (1987) (78)
Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD. (2012) (76)
Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. (1986) (76)
Problems with animal models of chronic liver disease: Suggestions for improvement in standardization (1989) (75)
Treatment of alcoholic hepatitis. (1998) (73)
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. (2021) (72)
Body composition and hepatic steatosis as precursors for fibrotic liver disease (1999) (71)
Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States. (2015) (69)
Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease. (2013) (68)
A Cost Analysis of Alternative Treatments for Duodenal Ulcer (1995) (67)
Gender differences in the regulation of amino acid metabolism. (2003) (65)
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. (2012) (65)
Measuring protein synthesis using metabolic ²H labeling, high-resolution mass spectrometry, and an algorithm. (2011) (65)
Metabolic syndrome, non‐alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response (2009) (63)
Should all pregnant women be screened for hepatitis B? (1987) (63)
Immediate diagnostic criteria for bacterial infection of ascitic fluid. Evaluation of ascitic fluid polymorphonuclear leukocyte count, pH, and lactate concentration, alone and in combination. (1986) (63)
Protein-calorie malnutrition and the etiology of cirrhosis. (1997) (62)
Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances. (2017) (61)
The impact of obesity and metabolic syndrome on alcoholic liver disease. (2014) (59)
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis. (2019) (58)
Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. (2008) (58)
Altered expression of genes regulating skeletal muscle mass in the portacaval anastomosis rat. (2007) (58)
Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature. (1999) (58)
Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease (2017) (58)
Relations of Steatosis Type, Grade, and Zonality to Histological Features in Pediatric Nonalcoholic Fatty Liver Disease (2011) (58)
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. (2012) (57)
Malnutrition in liver disease (2000) (55)
The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease. (1981) (55)
Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients☆ (2014) (54)
Body cell mass and leucine metabolism in cirrhosis. (1992) (52)
Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. (2016) (51)
Erratum: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference (Hepatology (2003) 37 (1202-1219)) (2003) (50)
Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. (2013) (50)
The efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel preparation for elective colonic surgery: a randomized, prospective, blinded clinical trial. (1985) (49)
Editorial: Non-Alcoholic Fatty Liver Disease and Obesity: Not All About Body Mass Index (2012) (49)
Nutritional therapy and liver disease. (1989) (49)
Effect of cirrhosis on energy expenditure. (1999) (48)
Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. (1988) (48)
Quantification of gluconeogenesis in cirrhosis: response to glucagon. (1998) (47)
Obesity and its nurturing effect on hepatitis C (2003) (46)
Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis (2019) (45)
A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. (1987) (45)
Improving compliance with postpolypectomy surveillance guidelines: an interventional study using a continuous quality improvement initiative. (2006) (44)
Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits* (2018) (44)
Increased Serum Levels of Carbohydrate Antigen 19-9 and Outcomes in Primary Sclerosing Cholangitis Patients Without Cholangiocarcinoma (2013) (43)
Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion. (2009) (43)
Relationship between three commonly used non‐invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non‐alcoholic steatohepatitis (2019) (42)
Comparison of leucine kinetics in endurance-trained and sedentary humans. (1999) (42)
Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide. (1983) (42)
Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitis (1993) (40)
Thiazolidinediones for nonalcoholic steatohepatitis--promising but not ready for prime time. (2006) (39)
Alcoholic Liver Disease (2010) (39)
Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis. (2012) (38)
Plasma Proteome Dynamics: Analysis of Lipoproteins and Acute Phase Response Proteins with 2H2O Metabolic Labeling* (2012) (37)
Management of ascites. (1985) (37)
Considerations for bariatric surgery in patients with cirrhosis. (2018) (36)
Keratin 18 is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis. (2019) (35)
2H2O-Based High-Density Lipoprotein Turnover Method for the Assessment of Dynamic High-Density Lipoprotein Function in Mice (2013) (35)
Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis (2014) (35)
In vivo differences between the turnover rates of leucine and leucine's ketoacid in stable cirrhosis. (1992) (34)
Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group. (1992) (34)
Prevalence of celiac disease in cirrhosis and outcome of cirrhosis on a gluten free diet: a prospective study. (2014) (33)
Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease (2019) (32)
Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip (2017) (32)
Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion (1998) (32)
Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation. (2017) (31)
Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation (2017) (31)
Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. (2013) (31)
Erratum: Nonalcoholic fatty liver disease in patients with type 2 diabetes (Clinical Gastroenterology and Hepatology (2004) 2 (262-265)) (2004) (31)
Obstructive Sleep Apnea and the Liver. (2019) (31)
Percutaneous endoscopic gastrostomy: another cause of "benign" pneumoperitoneum. (1984) (29)
Quantification of carbohydrate oxidation by respiratory gas exchange and isotopic tracers. (1995) (29)
Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension (2018) (29)
Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease (2019) (28)
Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. (2009) (27)
Diagnosis and Management of Alcoholic Liver Disease (2015) (27)
Relationship between leucine oxidation and oxygen consumption during steady-state exercise. (2001) (27)
A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. (1986) (25)
Overview: An Introduction to NASH and Related Fatty Liver Disorders (2007) (23)
A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. (1990) (23)
Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort (2019) (23)
Serial determinations of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis. (1987) (23)
Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease (2020) (23)
The influence of portacaval anastomosis on gonadal and anterior pituitary hormones in a rat model standardized for gender, food intake 9 and time after surgery (1991) (23)
Inhibition of aromatase improves nutritional status following portacaval anastomosis in male rats. (2006) (22)
Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans. (2008) (22)
Erratum: The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue (Cell Reports (2017) 19(12) (2451–2461) (S2211124717307519) (10.1016/j.celrep.2017.05.077)) (2017) (21)
Safety and efficacy of bariatric surgery in patients with advanced fibrosis (2017) (21)
Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome (2020) (20)
AASLD PRACTICE GUIDELINES Alcoholic Liver Disease (2009) (20)
Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy (1994) (20)
Future trends in hepatology: Challenges and opportunities (2008) (20)
Corticosteroids are effective in patients with severe alcoholic hepatitis. (1999) (20)
Nutritional effects of alcoholism (2000) (19)
ß-Hydroxybutyrate is Reduced in Humans with Obesity-Related NAFLD and Displays a Dose-Dependent Effect on Skeletal Muscle Mitochondrial Respiration In Vitro. (2020) (19)
Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon‐α (1994) (19)
Preservation of Portal Pressure Improves Growth and Metabolic Profile in the Male Portacaval-Shunted Rat (2002) (19)
Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. (1996) (19)
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study (2021) (19)
Glutamine--a conditionally essential amino acid in cirrhosis? (1995) (19)
HDL Flux is Higher in Patients with Nonalcoholic Fatty Liver Disease. (2019) (19)
Nonalcoholic Fatty Liver Disease (2001) (19)
Detection and Characterization of Endogenous Benzodiazepine Activity in Both Animal Models and Humans with Hepatic Encephalopathy (1989) (19)
Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double‐blind, placebo‐controlled study (2006) (18)
Gender‐dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt (1994) (18)
Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease (2018) (18)
Differences in amino acid kinetics in cirrhosis. (1993) (18)
Effect of corticotropin-like intermediate lobe peptide on pancreatic exocrine function in isolated rat pancreatic lobules. (1984) (18)
Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease. (2016) (16)
Interobserver Variability in Scoring Liver Biopsies with a Diagnosis of Alcoholic Hepatitis (2017) (16)
Leptin and the gastrointestinal tract. (2000) (16)
An Improved Measurement of Isotopic Ratios by High Resolution Mass Spectrometry (2013) (16)
Age Impacts Ability of Aspartate–Alanine Aminotransferase Ratio to Predict Advanced Fibrosis in Nonalcoholic Fatty Liver Disease (2015) (16)
Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD. (2016) (16)
Non-Alcoholic Fatty Liver Disease: A Practical Guide (2013) (16)
Differences in regulation of type I collagen synthesis in primary and passaged hepatic stellate cell cultures: the role of α5β1-integrin (2007) (16)
Association between fatigue and decreased survival in primary biliary cirrhosis. (2007) (16)
Omeprazole versus placebo in duodenal ulcer healing. The United States experience. (1990) (15)
The association of nonalcoholic steatohepatitis and obstructive sleep apnea (2017) (15)
Alteration in body composition in the portacaval anastamosis rat is mediated by increased expression of myostatin. (2011) (15)
Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients (2014) (15)
Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis (2021) (15)
AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review. (2020) (15)
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans (2021) (15)
Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites. (2011) (14)
Steroids or cocktails for alcoholic hepatitis. (2006) (14)
Obesity, hepatic metabolism and disease. (2009) (14)
Branched‐Chain Amino Acids as Nutritional Therapy in Liver Disease: Dearth or Surfeit? (2007) (13)
The development of a non‐invasive model to predict the presence of non‐alcoholic steatohepatitis in patients with non‐alcoholic fatty liver disease (2016) (13)
A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH (2019) (13)
Association between small intestinal bacterial overgrowth and deep vein thrombosis (2016) (13)
Beta-adrenergic blockade heightens the exercise-induced increase in leucine oxidation (1995) (13)
comparison Of Adult And Pediatric Nafld—confirmation Of A Second Pattern Of Progressive Fatty Liver Disease In Children : 189 (2006) (13)
A Western diet induced NAFLD in LDLR(-/)(-) mice is associated with reduced hepatic glutathione synthesis. (2016) (13)
Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. (2019) (12)
Spontaneous bacterial peritonitis caused by Neisseria gonorrhoeae. Evidence for a transfallopian route of infection. (1985) (12)
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms (2022) (12)
Higher visceral to subcutaneous fat ratio is associated with small intestinal bacterial overgrowth. (2016) (12)
IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis (2022) (12)
Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in U.S. Adults With Type 2 Diabetes. (2019) (11)
Acute Alcoholic Hepatitis, the Clinical Aspects. (2016) (11)
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis (2019) (11)
Corticosteroids Are Effective in Patients With Severe Alcoholic Hepatitis (1999) (11)
Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation (2016) (11)
Diabetes Mellitus, Insulin, Sulfonylurea and Advanced Fibrosis in Non- Alcoholic Fatty Liver Disease (2014) (10)
Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease (2018) (10)
Stable isotope-based flux studies in nonalcoholic fatty liver disease. (2018) (10)
Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease (2019) (10)
Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? (2017) (10)
The risks of percutaneous liver biopsy (2001) (9)
Diagnostic and Prognostic Significance of Complement in Patients With Alcohol‐Associated Hepatitis (2020) (9)
Omeprazole versus placebo in duodenal ulcer healing (2005) (9)
Beta-adrenergic blockade heightens the exercise-induced increase in leucine oxidation. (1994) (9)
Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis (2017) (9)
Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease (2020) (8)
Differences in regulation of type I collagen synthesis in primary and passaged hepatic stellate cell cultures: the role of alpha5beta1-integrin. (2007) (8)
Assessing liver fibrosis without biopsy in patients with HCV or NAFLD (2019) (8)
Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice (2022) (8)
Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. (2020) (8)
The association of nonalcoholic steatohepatitis and hepatocellular carcinoma (2020) (8)
Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience (2019) (8)
Relationship Between Three Commonly Used Non-invasive Fibrosis Biomarkers and Improvement in Fibrosis Stage in Patients With NASH. (2018) (8)
Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission database (2020) (8)
A continuous quality improvement initiative reduces inappropriate prescribing of prophylactic antibiotics for endoscopic procedures (1999) (7)
Hepatic mitochondrial defects in a mouse model of NAFLD are associated with increased degradation of oxidative phosphorylation subunits (2018) (7)
Serum Tricarboxylic Acid Cycle Intermediates: Potential Biomarker for Hyperammonemic Metabolic Dysregulation in Human Cirrhosis (2017) (7)
Diagnostic and prognostic implications of plasma amino acid determinations in chronic active hepatitis (1985) (7)
Carbachol modulates GIP-mediated insulin release from rat pancreatic lobules in vitro. (1985) (7)
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. (2017) (7)
Nutritional state and abnormal metabolism of nutrients (1995) (7)
Dietary Manipulations for Nonalcoholic Fatty Liver Disease (NAFLD) (2019) (7)
What's Hot in the Red Journal This Month? (2010) (6)
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD) (2022) (6)
932 Pentoxifylline Improves Non-Invasive Serum Markers of Fibrosis: Combined Results From 2 Randomized, Placebo-Controlled Trials (2012) (6)
Toothpick in ano: an unusual cause of syncope. (1994) (5)
Spontaneous bacterial peritonitis caused by Neisseria gonorrhoeae (1985) (5)
Commentary: Gastroenterology and Hepatology: An Evolving Marriage, Not an Imminent Divorce (2009) (4)
The effect of alcohol on body composition. (2000) (4)
Afternoon Colonoscopies Have Higher Failure Rates Compared to Morning Colonoscopies (2005) (4)
Pharmacologic Management of Non-Alcoholic Fatty Liver Disease (2014) (4)
Chapter Five – Nutrition and malnutrition in liver disease (2006) (4)
Comparison of Polyp Detection Rates During Colonoscopy by Attending Staff Alone Versus Trainee Plus Attending Staff: Are Two People Better Than One? (2005) (4)
Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD (2020) (4)
Blood-brain barrier (BBB) permeability. (1988) (4)
Non-Alcoholic Fatty Liver Disease Non-Alcoholic Fatty Liver Disease (2013) (3)
Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival (2021) (3)
Accuracy of Steatosis and Fibrosis NAFLD scores in relation to Vibration Controlled Transient Elastography: an NHANES analysis. (2022) (3)
The effect of alcohol on body composition (2000) (3)
Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes (2019) (3)
290 Cumulative Incidence and Risk Factors of Hepatocellular Carcinoma (HCC) in Patients with END-Stage Liver Disease Secondary to Nonalcoholic Steatohepatitis (NASH) (2009) (3)
Antemortem diagnosis and short-term survival of a patient with Wilson's disease presenting as fulminant hepatic failure (1984) (3)
Chapter 12 – Malnutrition in Cirrhosis (2006) (3)
Reply to: “Smoking and NASH: A hidden message from the GREACE trial” (2012) (3)
Nonalcoholic fatty liver disease: Risk factors and long-term outcomes for benign versus aggressive disease (1998) (2)
Impact of transjugular intrahepatic portosystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis (2013) (2)
Practical Management of Liver Diseases: Alcoholic Liver Disease (2008) (2)
On the safety of “Golytely” (1984) (2)
Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study (2022) (2)
Association Between Aspirin and Statin Use and the Prevalence of Non-Alcoholic Fatty Liver Disease: A Cross Sectional Study from National Health and Nutrition Examination Survey (1999-2012) (2017) (2)
Pathophysiology of Nonalcoholic Steatohepatitis. (2006) (2)
M1002 Treatment of Alcoholic Hepatitis (AH) in Clinical Practice (2009) (2)
Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis (2022) (2)
Liver Transplantation for Hepatocellular Carcinoma among African Americans in the United States (2012) (2)
Lack of a direct effect of the autonomic nervous system on glucose-stimulated gastric inhibitory polypeptide (GIP) secretion in man (1986) (2)
Mo1557 Evaluation of Effects of Concomitant Medications for NASH and Associated Comorbidities on Histological Improvements With Obeticholic Acid (2016) (2)
Clinico-pathologic features of non-alcoholic fatty liver disease predicting outcome (1998) (2)
Pregnancy outcomes and reproductive health after liver transplantation (2015) (2)
110 Over Twenty Five Years of Follow Up for a Non-Alcoholic Fatty Liver Disease (NAFLD) Cohort (2008) (2)
High prevalence of normal serum albumin in NASH patients with ascites: a retrospective analysis. (2013) (2)
Prophylactic β‐blocker therapy: Clinical implications of an aggregate analysis (1992) (2)
Do Corticosteroids Reduce Mortality from Alcoholic Hepatitis (2020) (1)
CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Ascitic Fluid Lactoferrin for Diagnosis of Spontaneous Bacterial Peritonitis (2008) (1)
Relapse following treatment withdrawal in autoimmune chronic active hepatitis. (1984) (1)
Prophylactic sclerotherapy: meta-analysis versus 'aggregate' analysis. (1992) (1)
How good is transjugular liver biopsy for the histological evaluation of liver disease? (2007) (1)
Short‐term aerobic exercise improves hepatic lipid composition, insulin sensitivity, and circulating HMW adiponectin independent of weight loss in patients with non‐alcoholic fatty liver disease (2011) (1)
What is Non‐Alcoholic Fatty Liver Disease (NAFLD), and Why is it Important? (2013) (1)
The Utility of Tacrolimus in the Management of Adults with Difficult-to-Treat Autoimmune Hepatitis: Review of Literature: 878 (2016) (1)
Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis C (2003) (1)
478 Assessing the Relation Between Irritable Bowel Syndrome and Nonalcoholic Liver Disease (2019) (1)
410 24-WEEK TREATMENT WITH CTS-1027 IN COMBINATION WITH RIBAVIRIN REDUCES HCV-RNA IN TREATMENT NAIVE GENOTYPE-1 PATIENTS (2011) (1)
482 NASH Recurrence and Rate of Fibrosis Progression Following Liver Transplantation (2014) (1)
SHOULD PREGNANT WOMEN BE SCREENED FOR HEPATITIS B? (1984) (1)
Pentoxifylline Improves Nonalcoholic Steatohepatitis: Results of a Double-blinded, Randomized, Placebo-Controlled Trial: 2010 ACG Governors Award Recipient for Excellence in Clinical Research: 308 (2010) (1)
Evaluation of Effects of Concomitant Medications for Non-Alcoholic Steatohepatitis and Associated Comorbidities on Histological Improvements with Obeticholic Acid (2016) (1)
Interaction of steatosis and non-alcoholic steatohepatitis (NASH) with chronic hepatitis C (2003) (1)
Re: [13C]urea breath test for Helicobacter pylori infection. (1996) (1)
Comprehensive hepatitis empowerment program (C-HEP) improves awareness and follow-up across ethnic groups in patients with positive HCV antibody (2000) (1)
Obesity, Inflammation, Nonalcoholic Fatty Liver Disease, and Hepatocellular Carcinoma (2013) (1)
The hepatic phase of glucose homeostasis in man (1978) (1)
EVALUATION OF ACUTE PANCREATITIS AND CANNABIS ABUSE ASSOCIATION AND OUTCOMES: A CROSS SECTIONAL STUDY USING LARGE INPATIENT DATA (2019) (1)
Predictors of Improvement in NAFLD Activity Score on Placebo: A Secondary Analysis of the Flint Trial (2016) (1)
Higher Mortality Among Liver Transplant Patients with Clostridium Difficile Infection: Meta-Analysis (2017) (1)
Immunomodulation Therapy for Alcoholic Hepatitis (2007) (1)
Worrisome disposition of hepatitis C antibody positive patients (1998) (1)
Stable isotopes and urinary nitrogen in the assessment of protein oxidation in cirrhosis. (1993) (1)
Serial determinattons of serum amino acids in chronic active liver disease (CALD) (1978) (1)
Strategies for the evaluation of nonalcoholic steatohepatitis (2007) (1)
S0997 The Prevalence of Gastrointestinal Tract (GIT) and Non-GIT Cancers in Non-Alcoholic Fatty Liver in the USA: A Population-Based Study (2020) (0)
Tu1448 - 30-Day Readmission Rate after Transjugular Intrahepatic Portosystemic Shunt (2018) (0)
NASH Patients With Ascites Frequently Have Normal Serum Albumin, but a Higher Mortality When Low Albumin Occurs (2011) (0)
Mo1473 THE ASSOCIATION OF ASPIRIN AND THE PROGRESSION OF LIVER DISEASE IN NAFLD PATIENTS: A POPULATION-BASED STUDY (2020) (0)
Author response: Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice (2022) (0)
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans (2022) (0)
Mo1466 RATES OF AND FACTORS AFFECTING DISCORDANCY IN STEATOSIS AS MEASURED ON FIBROSCAN COMPARED WITH BIOPSY IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS. (2020) (0)
Correspondence (0)
The Outcome of Acute Pancreatitis in Patients With Cannabinoid Abuse (2018) (0)
Intra-abdominal Xanthogranulomatoses Secondary to Postoperative Bile Leak (2015) (0)
Risk Factors of Non-alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease: 365 (2012) (0)
Alcohol in Non‐Alcoholic Fatty Liver Disease: an Oxymoron or a New Standard of Care? (2013) (0)
395 Small Intestine Bacterial Overgrowth Increases the Risk of Coronary Artery Disease (CAD) (2015) (0)
Sa1055 Use of Insulin and Sulfonylurea Is Associated With Hepatic Fibrosis in Diabetic Patients With Non-Alcoholic Fatty Liver Disease (2014) (0)
Mo1455 EVALUATION OF FIBROSCAN-AST (FAST™) SCORE FOR THE DETECTION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WHO ARE AT-RISK FOR FIBROTIC NONALCOHOLIC STEATOHEPATITIS (NASH). (2020) (0)
The Association Between Cannabinoid Abuse and Acute Pancreatitis (2018) (0)
Response to: Laboratory assessment may be dependent on the time of liver biopsy (2015) (0)
IRS-1-associated PI3-kinase in human skeletal muscle Regular exercise enhances insulin activation of (2015) (0)
Gender difference and hepatocellular carcinoma incidence in non-alcoholic steatohepatitis patients with advanced liver fibrosis (2020) (0)
Clinical Predictors of High Healthcare Utilization Among Patients With Acute Cholangitis: Analysis From the National Readmission Database (2018) (0)
943 A Step-Wise Approach to Non-Invasive Diagnosis of Advanced Fibrotic Disease in NAFLD (2019) (0)
Framingham Risk Score Predicts Severity of Fibrosis but Not Necro-Inflammation in Patients with Non Alcoholic Steatohepatitis (NASH) Presidential Poster: 445 (2012) (0)
Sa1774 – Increased Prevalence of Nonalcoholic Liver Disease in Crohn's Disease: A Population-Based Study (2019) (0)
Validation of the accuracy of the fast score for detecting non-alcoholic steatohepatitis patients at high risk of becoming cirrhotic in a North American cohort (2020) (0)
Su1528 - A Population-Based Prevalence of Nonalcoholic Fatty Liver Disease Associated Comorbidities and Pioglitazone Use Among us Adults with type 2 Diabetes (2018) (0)
973 Utility of Gram Stain in the Diagnosis and Management of Spontaneous Bacterial Peritonitis: Promoting High Value Care (2019) (0)
Su1514 - Prevalence of Nonalcoholic Fatty Liver Disease Associated Comorbidities in us Adults with Prediabetes: A Population-Based Analysis (2018) (0)
Response from Authors of HEP-21-2131.R1. (2022) (0)
S0089 Acute Pancreatitis and Metabolic Syndrome: Prevalence, Trends, and Outcomes (2020) (0)
metabolismdifferences in the regulation of amino acid (2015) (0)
Tu1488 – Hepatitis C-Cirrhosis and Mortality in a National Inpatient Population (2019) (0)
DIFFERENCES IN TREATING PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (1995) (0)
T1623 Differences in Gene Expression in Periportal Acinar Zones in Livers from Insulin Resistant L-SACC1 Mice (2009) (0)
The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis. (2023) (0)
Su1591 Effect of Insulin on Hepatic Collagen Deposition (2012) (0)
Sa1618 – Characteristics of Nonalcoholic Fatty Liver Disease in Patients with Severe Obesity: Insights from 3077 Consecutive Liver Biopsies (2019) (0)
Sa1513 THE RISK OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC PATIENTS WITH HEPATITIS B VIRUS INFECTION (2020) (0)
Mo1539 – Assessing the Risk for Acute Ischemic Bowel Disease in Irritable Bowel Syndrome Patients (2019) (0)
Which patients with nonalcoholic fatty liver disease should undergo liver biopsy? (2017) (0)
Su1479 - Cirrhotic Patients with an Increased Risk for In-Hospital Death (2018) (0)
Identificaiton of Non‐Alcoholic Steatohepatitis (NASH) Using Plasma Metabolome in Humans (2008) (0)
Su1533 - Validation of Noninvasive Fibrosis Scores in Prediabetic Patients with Nonalcoholic Fatty Liver Disease (2018) (0)
Mo1457 – The Risk of Hepatocellular Carcinoma in Cirrhotic Patients with Hbv and Hcv Infection: Not an Equal Opportunity (2019) (0)
Accuracy of ultrasonographic fatty liver index using point-of-care ultrasound in stratifying non-alcoholic fatty liver disease patients (2023) (0)
Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip (2017) (0)
Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort (2017) (0)
Abstract 14039: A Diet Induced Atherosclerosis in LDLR-/- Mice Is Associated With Altered HDL Proteome Dynamics (2013) (0)
Reply: (2007) (0)
59 Mass Spectrometric Detection of Lipid Oxidation Products in Murine and Human Nonalcoholic Fatty Liver Disease (2008) (0)
946 Factors Leading to Discordance Between Vibration-Controlled Transient Elastography and Liver Biopsy in Patients With Non-Alcoholic Fatty Liver Disease (2019) (0)
The Relationship of Steatosis Grade, Zone and Type to Key Histological Features in Children with Nonalcoholic Fatty Liver Disease: 1451 (2009) (0)
794 - Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Absorption of Macronutrients, Body Weight and Lean Body Mass in Patients with Short Bowel Syndrome (2018) (0)
1051 Association Between Vitamin D Deficiency and Nonalcoholic Fatty Liver Disease (NAFLD) (2019) (0)
Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD—not everyone fits the mould. Authors' reply (2022) (0)
26. Alcoholic Liver Disease (2011) (0)
Su1569 - Pattern of Diuretic Use Before and after Transjugular Intrahepatic Portosystemic Shunt (2018) (0)
Mo1031 Histological and Portal Pressure Correlation in Non-Alcoholic Fatty Liver Disease (2014) (0)
womentolerance, and body composition in older Effects of HRT and exercise training on insulin action, (2015) (0)
Nutrition in critically ill patients with gastrointestinal and hepatic diseases (1989) (0)
Induction vs. Standard interferon monotherapy for patients with HCV viremia and normal ALT (2000) (0)
Small Intestinal Bacterial Overgrowth Is Associated With Higher Visceral Fat: 2414 (2015) (0)
Correspondence. Liver Blood Flow Using Clearance Techniques (1984) (0)
Intra-Abdominal Xanthogranulomatosis Secondary to Postoperative Bile Leak: 1062 (2014) (0)
Reply Letter (to 19-1600). (2019) (0)
S3257 A Comparison of Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) and Obese NAFLD Patients (2020) (0)
13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS (2021) (0)
Recurrent Primary Sclerosing Cholangitis in Transplanted Liver: A Longitudinal Cohort (2018) (0)
CONTINUOUS QUALITY IMPROVEMENT (CQI) INITIATIVE ENHANCES COMPLIANCE WITH POST-POLYPECTOMY SURVEILLANCE GUIDELINES: 999 (2004) (0)
Sa1654 MELD Scores Correlate With Survival and Circulating Markers of Microbial Translocation, Danger Signals, and Inflammatory Markers: sCD163 Predicts Survival in Patients With Alcoholic Hepatitis (2016) (0)
and sedentary humans Comparison of leucine kinetics in endurance-trained (2015) (0)
S1122 Outcomes of Infective Endocarditis in Cirrhosis: A Propensity-Matched Study (2020) (0)
Increased Soluble Fas and Fas Ligand Levels in Patients with Nonalcoholic Steatohepatitis: 315 (2008) (0)
“Spontaneous” bacterial peritonitis: Transfallopian route of infection confirmed (1986) (0)
793 - Comparison of Prediction Models of Advanced Fibrosis in Morbidly and Non-Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease (2018) (0)
Colour Plate Section (2004) (0)
2958 Assessing the Association Between Psoriasis and Nonalcoholic Liver Disease (2019) (0)
Criteria of abnormality in liver scinti scans based on computerized evaluation (1984) (0)
S1165 The Risk of Cirrhosis in Nonalcoholic Fatty Liver Disease: A Population-Based Study (2020) (0)
NASH decompensation and portal pressures. (2023) (0)
Assessment of the Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease: 404 (2009) (0)
Reply: (2020) (0)
S1074 LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients (2020) (0)
The interaction of gastric inhibitory polypeptide, carbamylcholine, glucose and amino acids upon insulin secretion (1982) (0)
Su1397 Very Low and Similar Proportions of Patients With Celiac Disease Among Patients With Normal and Elevated ALT Levels, Especially Among Non-Whites: Results of a U.S. Nationwide Sample of 16,795 Persons (2015) (0)
Mo1458 DISCORDANCY IN FIBROSIS SCORE ON FIBROSCAN COMPARED WITH LIVER BIOPSY AND ITS RELATIONSHIP TO FATTY LIVER DISEASE IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS. (2020) (0)
Tu1632 High Visceral Fat Area Is Association With Postoperative Complications in Patients With Crohn's Disease Following Primary Surgery (2014) (0)
Su1041 Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome Are Associated With Small Intestine Bacterial Overgrowth (2015) (0)
Small Intestinal Bacterial Overgrowth Increases the Risk for Deep Vein Thrombosis: 2380 (2015) (0)
Assessment of Endoscopic Skills of Gastroenterology Trainees by Self-Evaluation, Endoscopy Nurses and Attendings: Correlation Between Three Sides of the Story (2005) (0)
Rate of Fibrosis Progression Following Liver Transplantation in NASH.: Abstract# A413 (2014) (0)
Prophylactic beta-blocker therapy: clinical implications of an aggregate analysis. (1992) (0)
The point of care 13C-Methacetin Breath Test predicts risk of long-term liver-related death or transplantation in patients with chronic liver disease: a sensitive, noninvasive monitoring tool in clinical hepatology (2017) (0)
UNCORRECTED PROOF 1 Clinical spectrum of non-alcoholic fatty liver disease in diabetic and 2 non-diabetic patients☆ (2014) (0)
Assessing the Risk of Osteoporosis in Patients with Inflammatory Bowel Disease (2018) (0)
Tu1519 - The Impact of Probiotics on Nonalcoholic Fatty Liver Disease: Meta-Analysis (2018) (0)
Estimates of Hepatic Glyceroneogenesis in Type 2 Diabetes in Humans (2008) (0)
Hepatic response to dose-related intraduodenal and intravenous glucose infusion in man (1979) (0)
Trends and Risk Factors for 30-Day Readmissions in Patients With Acute Cholangitis: Analysis From the National Readmission Database: Presidential Poster Award (2018) (0)
Tacrolimous in the Management of Difficult-to-Treat Autoimmune Hepatitis: 2107 (2015) (0)
Malnutrition and Nutrition in Liver Disease (2010) (0)
Mo1469 PREVALENCE AND FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN CIRRHOTIC AND NON-CIRRHOTIC NONALCOHOLIC FATTY LIVER DISEASE PATIENTS: A POPULATION-BASED STUDY (2020) (0)
Trends and outcomes of infective endocarditis in cirrhosis: a propensity-matched national study (2021) (0)
Complete Blood Cell Count Biomarkers Provide No Additional Benefit Over Traditional Lipid Biomarkers for Assessing Cardiovascular Disease Risk in Non-alcoholic Steatohepatitis: 366 (2012) (0)
1190 Does Nonalcoholic Fatty Liver Disease Increase the Risk for Acute Ischemic Bowel Disease? (2019) (0)
Sa1535 - Comparative Efficacy Between Self-Expandable Metallic Stent and Plastic Stent in the Management of Anastomotic Biliary Stricture (2018) (0)
New treatments for alcoholic liver disease. (1994) (0)
461 Outcome of Patients With Hepatocellular Carcinoma Beyond Milan Criteria (2012) (0)
Sa1773 – Nonalcoholic Liver Disease Significantly More Prevalent in Ulcerative Colitis: A Population-Based Study (2019) (0)
Mo1499 THE PREVALENCE AND EPIDEMIOLOGY OF ACUTE PANCREATITIS IN NON-ALCOHOLIC FATTY LIVER IN THE USA: A POPULATION-BASED STUDY (2020) (0)
Sa1039 Renin Angiotensin System and Fibrosis in NAFLD (2014) (0)
The Impact of the Endoscopy Nurse on Colonoscopy Completion Rates (2005) (0)
915 90-DAY MORTALITY PREDICTION OF A NOVEL SCORE BASED ON THE COMBINATION OF IL-6, IL-13 AND AGE IS SUPERIOR TO MELD SCORE IN SEVERE ALCOHOLIC HEPATITIS (2020) (0)
Real World Experience With Vitamin E and Pentoxifylline for the Treatment of Nonalcoholic Steatohepatitis: 2007 (2015) (0)
S1014 Natural History of Nonalcoholic Steatohepatitis (NASH) After Orthotopic Liver Transplantation (LT) (2009) (0)
Transjugular Intrahepatic Portosystemic Shunts (TIPS) is Associated with Increased Mortality in Patients After Orthotopic Liver Transplantation (OLT): Presidential Poster: 440 (2012) (0)
Asymmetric Dimethylarginine Levels in the Plasma Are Elevated in Non‐Alcoholic Fatty Liver Disease (2008) (0)
986 The Risk of Depression in Patients With Nonalcoholic Fatty Liver Disease (2019) (0)
Sa1565 – Higher Uric Acid Levels are Associated with Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD) (2019) (0)
PL-125 Reduced cardiovascular risk in obese patients after bariatric surgery is related to ceramide-mediated reduction in APO B level and (ApoB)/ (ApoA-I) ratio (2011) (0)
In Response. (2016) (0)
Predictive Values of HOMA and Metabolic Syndrome by Different Definitions in Identifying NASH and Liver Fibrosis in a Population with High Prevalence of Obesity and Diabetes: 356 (2007) (0)
Su1545 - The Association of Nonalcoholic Steatohepatitis and Inflammatory Bowel Disease (2018) (0)
Hepatic lipid saturation indices and insulin resistance in non‐alcoholic fatty liver disease (NAFLD) (2010) (0)
Sa352 DEVELOPMENT AND VALIDATION OF MACHINE LEARNING MODEL FOR DETECTION OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AT RISK OF PROGRESSION TO CIRRHOSIS (FIBROTIC-NASH). (2021) (0)
Mo1495 INFLAMMATORY DIET AND NON-ALCOHOLIC FATTY LIVER DISEASE: A NATIONAL HEALTH AND EXAMINATION SURVEY STUDY. (2020) (0)
Su1692 Post Liver Transplantation Sarcopenia in Cirrhosis: Mechanisms and Prospective Evaluation (2013) (0)
Mo1518 THE EPIDIMIOLOGY AND TREND ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE PREVALENCE BETWEEN 2006-2014: A POPULATION BASED STUDY (2020) (0)
Su1044 Is Bariatric Surgery Beneficial in Patients With NAFLD and Advanced Fibrosis (2015) (0)
Acute Alcoholic Hepatitis (2018) (0)
S1121 Role of Markers of Heavy Metal Metabolism in Identification of Hepatic Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) (2020) (0)
587 MACHINE LEARNING MODEL CORRECTLY IDENTIFIES PATIENTS WITH ADVANCED LIVER FIBROSIS WHICH ARE INDETERMINATE BY FIB-4 INDEX IN NON-ALCOHOLIC FATTY LIVER DISEASE. (2021) (0)
Alcohol-induced extracellular asc specks perpetuate liver inflammation and damage in alcoholic hepatitis even after alcohol cessation. (2023) (0)
Medical Management of Portal Hypertension and Its Complications (2017) (0)
Sa1642 – Trends in Inpatient Admissions and Healthcare Outcomes in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Analysis Using National Inpatient Sample Database (NIS) from 1998 to 2013 (2019) (0)
The effect of insulin (I), glucose (G) and glucose turnover upon the release and physiologic action of gastric inhibitory polypeptide (GIP) (1979) (0)
Tu1677 FURTHER ANALYSIS OF THE FIBROSCAN-AST (FAST™) SCORE FOR THE DETECTION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WHO ARE AT-RISK FOR FIBROTIC NONALCOHOLIC STEATOHEPATITIS (NASH). (2020) (0)

This paper list is powered by the following services:

Arthur Joseph Mccullough's Academic­Influence.com Rankings

Arthur Joseph Mccullough's Degrees

Why Is Arthur Joseph Mccullough Influential?

Arthur Joseph Mccullough's Published Works

Published Works

Arthur Joseph Mccullough's AcademicInfluence.com Rankings